Los Angeles, CA, January 9, 2013 -- USA Graphite Inc (OTC: USGT) augmented 1.16% to $0.950 on a traded volume of 251k shares. The stock is very close to the $1 mark. Recently, the Company informed its shareholders of its activities in selecting the location of a high-quality Canadian project for a potential acquisition. The Company has identified the West Coast of Canada as the ideal location to acquire a project that would significantly increase the Company's operations. Eagle Graphite, which is a privately held Canadian corporation, is located on the West Coast of Canada and is one of only two natural flake graphite mines operating in North America.
Will USGT Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=USGT
AMARANTUS BIOSCI INC (OTC: AMBS) soared 10.53% to $0.147. The Company presented positive preclinical efficacy data for MANF in a neurorestoration 6-hydroxydopamine rat model of Parkinson's disease. The data demonstrate that unlike Glial cell-Derived Neurotrophic Factor, MANF significantly reduces behavioral deficits, increases dopaminergic nerve terminal reinnervation of the striatum, and increases dopamine concentrations in the striatum when MANF is administered directly to the substantia nigra.
How Should Investors Trade AMBS After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=AMBS
Southridge Enterprises Inc (PINKSHEETS: SRGE) is currently trading at $0.0057. So far this year, the stock is up over 1533%. The 52-week range for the stock is $0.0 and $0.02. Southridge Minerals focuses on the acquisition, exploration, and development of gold and silver mines in Mexico.
Get Free Special Trend Analysis On SRGE Here http://beststocksdaily.com/p2/index.php?company=SRGE
Endeavor Power Corp (PINKSHEETS: EDVP) soared 5.33% to $0.079 on a traded volume of 169k shares. The Company provides an outline of its new target market in the Point-of-Care in Vitro diagnostics market. The point-of-care testing market has been predicted to reach a total market value of $34.6 billion by 2021. In addition, the management provided the reason for the shift from central laboratory to POCT.
Get Free Special Trend Analysis On EDVP Here http://beststocksdaily.com/p2/index.php?company=EDVP
Peregrine Pharmaceuticals (NASDAQ: PPHM) declined 8.15% to $2.14 on a traded volume of 91.02 million shares. The investors are examining Peregrine Pharmaceuticals after the company finally addressed the issues with the phase II data for the lung cancer treatment bavituximab publicly.
The Company said flaws in a study of its experimental lung cancer drug bavituximab didn’t extend to the highest treatment dose. An internal review found that discrepancies in a mid-stage study were limited to the placebo and low-dose treatments.
Get Free Special Trend Analysis On PPHM Here http://beststocksdaily.com/p2/index.php?company=PPHM
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 Westwood Blvd Los Angeles, CA